Phenylthiocarbamide (PTC) perception in ultra-high risk for psychosis participants who develop schizophrenia: Testing the evidence for an endophenotypic marker

Brewer, WJ; Lin, A; Moberg, PJ; Smutzer, G; Nelson, B; Yung, Alison; Pantelis, C; McGorry, PD; Turetsky, BI; Wood, SJ

File(s) not publicly available

Phenylthiocarbamide (PTC) perception in ultra-high risk for psychosis participants who develop schizophrenia: Testing the evidence for an endophenotypic marker

Version 2 2024-06-05, 11:24

Version 1 2022-11-30, 02:49

journal contribution

posted on 2024-06-05, 11:24 authored by WJ Brewer, A Lin, PJ Moberg, G Smutzer, B Nelson, Alison YungAlison Yung, C Pantelis, PD McGorry, BI Turetsky, SJ Wood

Phenylthiocarbamide (PTC) perception in ultra-high risk for psychosis participants who develop schizophrenia: Testing the evidence for an endophenotypic marker

History

Journal

Psychiatry Research

Volume

199

Pagination

8-11

Location

Ireland

Publisher DOI

https://doi.org/10.1016/j.psychres.2012.03.010

ISSN

0165-1781

eISSN

1872-7123

Language

English

Publication classification

C1.1 Refereed article in a scholarly journal

Issue

1

Publisher

ELSEVIER IRELAND LTD

Usage metrics

Keywords

Science & Technology Life Sciences & Biomedicine Psychiatry Taste Endophenotype Prediction Mental illness Psychosis Risk 1ST-DEGREE FAMILY-MEMBERS TASTE SENSITIVITY DIAGNOSIS GENETICS

Licence

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

File(s) not publicly available

Phenylthiocarbamide (PTC) perception in ultra-high risk for psychosis participants who develop schizophrenia: Testing the evidence for an endophenotypic marker

History

Journal

Volume

Pagination

Location

Publisher DOI

ISSN

eISSN

Language

Publication classification

Issue

Publisher

Usage metrics

Categories

Keywords

Licence

Exports